State Key Laboratory of Natural and Biomimetic Drugs, Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University Health Science Center, Peking University, No. 38, Xueyuan Road, Haidian District, Beijing 100191, China.
Molecules. 2019 Nov 12;24(22):4080. doi: 10.3390/molecules24224080.
Psoralen (P) and isopsoralen (IP) are the main active ingredients in the dried fruit of L. (PC), with a wide range of pharmacology activities. The intestinal bacteria biotransformation plays a central role in the metabolism of the complex ingredients in traditional Chinese medicine (TCM). Our study aimed to investigated the metabolic profile of P and IP in the intestinal condition, co-cultured with human fecal bacteria anaerobically. Four bio-transforming products were obtained, including 6,7-furano-hydrocoumaric acid (P-1) and 6,7-furano-hydro- coumaric acid methyl ester (P-2), which transformed from P, and 5,6-furano-hydrocoumaric acid (IP-1) and 5,6-furano-hydrocoumaric acid methyl ester (IP-2), which were transformed from IP. It is worth mentioning that IP-2 is a new compound that has not been published. Their structures were analyzed based on their spectroscopic data. Moreover, a highly sensitive ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method was used to characterize the metabolic pathways of P, IP, and their bio-transforming products in the reaction samples. In addition, the dampening effects against the oxidative stress of P, IP, and their bio-transforming products by human intestinal flora were estimated in vitro via the human colorectal cells (HCT116) and heterogeneous human epithelial colorectal adenocarcinoma cells (Caco-2) cell lines. The results showed that the metabolites have stronger activity than P and IP, which possibly provides a basis for elucidating the treating mechanisms of PC extract against inflammatory bowel disease.
补骨脂素(P)和异补骨脂素(IP)是补骨脂果实中主要的活性成分,具有广泛的药理学活性。肠道细菌生物转化在中药(TCM)复杂成分的代谢中起着核心作用。我们的研究旨在研究 P 和 IP 在肠道条件下与人粪便细菌厌氧共培养时的代谢谱。从 P 转化得到了 4 种生物转化产物,包括 6,7-呋喃型羟基香豆酸(P-1)和 6,7-呋喃型羟基香豆酸甲酯(P-2),从 IP 转化得到了 5,6-呋喃型羟基香豆酸(IP-1)和 5,6-呋喃型羟基香豆酸甲酯(IP-2)。值得一提的是,IP-2 是一种尚未发表的新化合物。它们的结构是根据其光谱数据进行分析的。此外,还采用高灵敏度超高效液相色谱串联质谱(UPLC-MS/MS)法对 P、IP 及其生物转化产物在反应样品中的代谢途径进行了表征。此外,还通过人结肠癌细胞(HCT116)和异质人上皮结肠直肠腺癌细胞(Caco-2)细胞系在体外评估了 P、IP 及其生物转化产物对人肠道菌群的抗氧化应激抑制作用。结果表明,代谢产物的活性强于 P 和 IP,这可能为阐明补骨脂提取物治疗炎症性肠病的机制提供了依据。